Recombinant Human CXX1 Protein，GST

CXX1, also known as Chemokine CXC motif ligand 1, is a crucial protein in the human immune system, primarily involved in the recruitment and activation of neutrophils during inflammatory responses. The study of CXX1 has gained significant attention due to its pivotal role in various pathological conditions, including cancer, chronic inflammation, and infectious diseases. Elevated levels of CXX1 have been observed in tumor microenvironments, suggesting its involvement in tumor progression and metastasis. Researchers have been investigating CXX1 as a potential biomarker for cancer diagnosis and a therapeutic target for modulating inflammatory responses. Recombinant CXX1 proteins are being developed to better understand its structure-function relationship and to elucidate the mechanisms underlying its activity. This research is vital for the development of CXX1-based therapies that could enhance immune response in infections or inhibit excessive inflammation in chronic diseases. Additionally, the recombinant protein can be used in therapeutic applications, such as improving wound healing or managing autoimmune disorders, making it a significant focus in both fundamental and translational research. Overall, the exploration of CXX1’s biochemical properties and its role in disease pathophysiology holds promise for future therapeutic innovations in immunology and oncology.